سعر مينازون 1مجم/جم مرهم 15 جم 2022

Mometasone furoate 1 mg/g (0.1%) ointment (Minasone; Mina Pharm), 15 g tube.

• Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients aged 2 years and older.Population: Adults and children aged 2 years and olderDailyMed (U.S. NLM)

• Reported local reactions include burning, pruritus, skin atrophy, tingling/stinging and furunculosis; rosacea has also been reported.International label, same formulation · DailyMed (U.S. NLM)

• Hypersensitivity to mometasone furoate or any component of the preparation.International label, same formulation · DailyMed (U.S. NLM)

• Systemic absorption can cause reversible HPA-axis suppression, Cushing's syndrome and hyperglycaemia, especially with large areas, prolonged use or occlusion; children are at higher risk.International label, same formulation · DailyMed (U.S. NLM)
• Topical corticosteroids may increase the risk of cataract and glaucoma; refer if visual symptoms occur.International label, same formulation · DailyMed (U.S. NLM)
• Allergic contact dermatitis may occur (failure to heal); concomitant skin infections need appropriate antimicrobial treatment and the corticosteroid may need to be stopped.International label, same formulation · DailyMed (U.S. NLM)

• No adequate controlled studies; observational data have not identified a drug-associated risk of major birth defects, but potent topical corticosteroids may be associated with low birth weight; use on the smallest area of skin for the shortest duration possible.International label, same formulation · DailyMed (U.S. NLM)
• Use on the smallest area for the shortest duration while breastfeeding; do not apply directly to the nipple and areola.International label, same formulation · DailyMed (U.S. NLM)

English text not available for this section.